Edition:
United States

Hill-Rom Holdings Inc (HRC.N)

HRC.N on New York Stock Exchange

71.14USD
21 Apr 2017
Change (% chg)

$-0.46 (-0.64%)
Prev Close
$71.60
Open
$71.49
Day's High
$71.49
Day's Low
$70.74
Volume
52,980
Avg. Vol
142,549
52-wk High
$71.81
52-wk Low
$46.79

Summary

Name Age Since Current Position

Rolf Classon

71 2006 Independent Chairman of the Board

Carlos Alonso

57 2015 President, Senior Vice President

Dirk Ehlers

56 2016 Senior Vice President, President - Surgical Solutions

John Greisch

61 2010 President, Chief Executive Officer, Director

Steven Strobel

58 2014 Chief Financial Officer, Senior Vice President

Kenneth Meyers

54 2015 Chief Human Resource Officer, Senior Vice President

Deborah Rasin

50 2016 Senior Vice President, Chief Legal Officer, Secretary

Andreas Frank

40 2011 Senior Vice President - Corporate Development and Strategy

Alton Shader

43 2015 Senior Vice President and President - Front Line Care

Jason Richardson

39 2016 Chief Accounting Officer, Vice President, Controller

Richard Keller

54 2016 Vice President - Internal Audit

Mary Garrett

58 2017 Director

Nancy Schlichting

62 2017 Director

William Dempsey

65 2014 Independent Director

James Giertz

59 2009 Independent Director

Charles Golden

70 2002 Independent Director

William Kucheman

67 2013 Independent Director

Ronald Malone

62 2007 Independent Director

Stacy Seng

52 2014 Independent Director

Biographies

Name Description

Rolf Classon

Mr. Rolf A. Classon is Independent Chairman of the Board of the company. Mr. Classon became Chairman of the Board of Hill-Rom in 2006. He served as Interim President and Chief Executive Officer of Hill-Rom from May 2005 until March 2006 and as Vice Chairman of the Board from December 2003 until his election as Interim President and Chief Executive Officer. From 2002 to 2004, Mr. Classon served as Chairman of the Executive Committee of Bayer Healthcare AG, the healthcare division of Bayer AG, a global healthcare and chemicals company, and, from 1995 to 2002, Mr. Classon served as President of Bayer Diagnostics. From 1991 to 1995, Mr. Classon was an Executive Vice President in charge of Bayer Diagnostics’ Worldwide Marketing, Sales and Service operations. From 1990 to 1991, Mr. Classon was President and Chief Operating Officer of Pharmacia Biosystems A.B. Prior to 1990, Mr. Classon served as President of Pharmacia Development Company Inc. and Pharmacia A.B.’s Hospital Products Division. Mr. Classon serves as a director of Fresenius Medical Care, Tecan Group and Catalent, Inc., and served as a director of Auxilium Pharmaceuticals, Inc. through January of 2015. Mr. Classon has extensive experience in the health care industry, including positions in management and on the boards of several companies. His service as a senior officer in numerous international corporations brings an extensive breadth of knowledge and valuable insight to the Board.

Carlos Alonso

Mr. Carlos Alonso is President, Senior Vice President of the company. Mr. Alonso was elected Senior Vice President and President, Hill-Rom International in April 2015. Before joining Hill-Rom, Mr. Alonso served as the President and CEO of the Esaote Group, a medical imaging leader based in Genova, Italy. Prior to the Esaote Group, Mr. Alonso served as the CEO of Esteve Pharmaceuticals based in Barcelona, Spain, and held various leadership roles of increasing responsibility with Baxter International, Inc. over the course of fifteen years, including serving as Global President of the Renal Division.

Dirk Ehlers

DR. Dirk Ehlers is Senior Vice President, President - Surgical Solutions of the company. in January 2016. He joined Hill-Rom in September 2015 to lead the Trumpf Medical business. Prior to joining Hill-Rom, Dr. Ehlers was the President and Chief Executive Officer of Eppendorf, a Life Science Tools company based in Germany. Prior to that, Dr. Ehlers was the Head of Professional Diagnostics with Roche Diagnostics, and spent six years as Chief Financial Officer and Business Unit Head for Evotec AG, a public contract research and biotech company.

John Greisch

Mr. John J. Greisch is President, Chief Executive Officer, Director of the company. Mr. Greisch was elected President & Chief Executive Officer of Hill-Rom effective January 8, 2010. Prior to that date, Mr. Greisch served as President International Operations for Baxter International, Inc., a position he held since 2006. During his seven-year tenure with Baxter, he also served as Baxter's Chief Financial Officer and as President of Baxter's BioScience division. Before his time with Baxter, he was President & CEO for FleetPride Corporation in Deerfield, Illinois, an independent after-market distribution company serving the transportation industry. Prior to his tenure at FleetPride, he held various positions at The Interlake Corporation in Lisle, Ill., a leading global engineered materials and industrial equipment supplier, including serving as President of the company's Materials Handling Group. Mr. Greisch currently serves on the Board of Directors for Actelion Ltd, and AdvaMed. Additionally, he is on the Board of Directors for Ann & Robert H. Lurie Children's Hospital of Chicago. As the CEO of Hill-Rom, Mr. Greisch brings valuable multinational experience with multiple roles in a major public healthcare company, including as Chief Financial Officer, as well as operational insights and business knowledge to the Board.

Steven Strobel

Mr. Steven J. Strobel has been appointed as Chief Financial Officer, Senior Vice President of the Company. He was elected Senior Vice President in November 2014 and Chief Financial Officer in December 2014. Before joining Hill-Rom, Mr. Strobel was President of McGough Road Advisors, a corporate finance consulting firm, from 2012 to 2014 and previously Chief Financial Officer of BlueStar Energy, an independent retail energy services company, from 2009 to 2012. Prior to BlueStar, he served as Treasurer and Corporate Controller at Motorola, and in the same positions at Owens Corning. Mr. Strobel serves on the Board of Directors of Newell Brands Inc., where he chairs the Audit Committee.

Kenneth Meyers

Mr. Kenneth F. Meyers is a Chief Human Resource Officer, Senior Vice President of the company. He was elected Senior Vice President and Chief Human Resources Officer, effective September 2015. Before joining Hill-Rom, Mr. Meyers was Senior Vice President and Chief Human Resources Officer at Hospira, Inc. Previously, he was a partner at Mercer / Oliver Wyman Consulting. Prior to Mercer / Oliver Wyman, he served as Senior Vice President, Human Resources, for Starbucks International.

Deborah Rasin

Ms. Deborah Rasin is Senior Vice President, Chief Legal Officer and Secretary of the company. She was elected Senior Vice President, Chief Legal Officer and Secretary for Hill-Rom, effective January 2016. Previously she was General Counsel for Dentsply Sirona, Inc. Prior to Dentsply, Ms. Rasin served as General Counsel at Samsonite Corporation (for which she worked in Denver and London) and as a senior attorney at GM (in Detroit and Zurich).

Andreas Frank

Mr. Andreas G. Frank is Senior Vice President - Corporate Development and Strategy of the company. He was elected as Senior Vice President Corporate Development and Strategy in October 2011. Before joining Hill-Rom, Mr. Frank was Director, Corporate Development at Danaher Corporation. Previously he worked in the Corporate Finance and Strategy practice at the consulting firm McKinsey & Company.

Alton Shader

Mr. Alton Shader is Senior Vice President and President - Front Line Care of the company. He was elected Senior Vice President and President, Front Line Care in September 2015. He had served as Senior Vice President and President, North America since July 2012 and previously as Senior Vice President and President, Post-Acute Care with Hill-Rom since July 2011. Before joining Hill-Rom, Mr. Shader was General Manager of Renal at Baxter International, Inc. Previously, he served as General Manager for Baxter Ireland and held senior marketing positions in Baxter's operations in Zurich and in California.

Jason Richardson

Mr. Jason A. Richardson is Vice President, Controller and Chief Accounting Officer of the Company. Mr. Richardson was elected Vice President, Controller and Chief Accounting Officer of the Company, effective March 2016. Mr. Richardson previously served in a variety of finance and accounting positions with Hill-Rom, including Assistant Controller and head of finance for Hill-Rom’s Surgical and Respiratory Care division.

Richard Keller

Mr. Richard G. Keller is Vice President - Internal Audit of the Company. Mr. Keller was Vice President, Chief Accounting Officer, Controller of Hill-Rom Holdings, Inc. He was elected Vice President, Controller and Chief Accounting Officer of the Company effective August 2005. He had served as Executive Director - Controller of Hill-Rom since March 2004.

Mary Garrett

Ms. Mary Garrett serves as Director of the Company. Ms. Garrett most recently led Global Marketing for IBM Corporation, until her retirement in December 2015.

Nancy Schlichting

Ms. Nancy M. Schlichting serves as Director of the Company. She is the retired president and CEO of Henry Ford Health System in Detroit, Michigan, having served in that role until December 2016.

William Dempsey

Mr. William G. Dempsey is Independent Director of the company. Mr. Dempsey has served as a director of Hill-Rom since 2014. Mr. Dempsey previously held various executive positions with Abbott Laboratories from 1982 until 2007, including, Executive Vice President of Global Pharmaceuticals from 2006, Senior Vice President of Pharmaceutical Operations from 2003 and Senior Vice President of International Operations from 1999. He currently serves as a director of Landauer Inc. and Ashland, Inc. (where he serves on the audit, environmental, health and safety, and quality committees), and was previously on the boards of MDS, Inc. through 2011, Nordion, Inc. through 2014 and Hospira, Inc., through 2015. He has previously served as a member of the Salvation Army Advisory Board in Chicago, as Chairman of the International Section of the Pharmaceutical Research and Manufacturers of America (PhRMA) and as Chairman of the Accelerating Access Initiative a cooperative public-private partnership of UNAIDS, the World Bank, and six research-based pharmaceutical companies. He is a member of the Board of Trustees for the Guadalupe Center in Immokalee, Florida.

James Giertz

Mr. James R. Giertz is Independent Director of the company. Mr. Giertz has served as a director of Hill-Rom since 2009. He was Executive Vice President and Chief Financial Officer of H.B. Fuller Company, St. Paul, Minnesota from March 2008 until April 2016. He is currently Executive Vice President, Strategy, for H.B. Fuller Company. Prior to joining H.B. Fuller, he served as Senior Managing Director, Chief Financial Officer and, for several months in 2007 a director, of Residential Capital, LLC, one of the largest originators, servicers and securitizers of home loans in the United States. Prior to that, he was Senior Vice President of the Industrial Products division, and Chief Financial Officer of Donaldson Company, Inc., a worldwide provider of filtration systems and replacement parts. In addition, Mr. Giertz served as assistant treasurer of the parent company at General Motors, and also held several international treasury positions in Canada and Europe. Mr. Giertz also serves on the Board of the Junior Achievement of the Upper Midwest and the Board of Regents of Concordia University of St. Paul.

Charles Golden

Mr. Charles E. Golden is Independent Director of the company. Mr. Golden has served as director of Hill-Rom since 2002. He served as Executive Vice President and Chief Financial Officer and a director of Eli Lilly and Company, an international developer, manufacturer and seller of pharmaceutical products, from 1996 until his retirement in 2006. Prior to joining Eli Lilly, he had been associated with General Motors Corporation since 1970, where he held a number of positions, including Corporate Vice President, Chairman and Managing Director of the Vauxhall Motors subsidiary and Corporate Treasurer. He is currently on the board of Eaton Corporation PLC, and was formerly on the boards of Unilever NV/PLC through 2014. He also serves as a director of the Lilly Endowment and Indiana University Health.

William Kucheman

Mr. William H. Kucheman is Independent Director of the company. Mr. Kucheman has served as a director of Hill-Rom since 2013. He previously served as interim Chief Executive Officer for Boston Scientific Corp. Before being named interim CEO in October 2011, he was Executive Vice President and President of the Cardiology, Rhythm and Vascular (CRV) Group of Boston Scientific. He joined the company in 1995 as a result of Boston Scientific’s acquisition of SCIMED Life Systems, Inc., becoming Senior Vice President of Marketing. In this role, Mr. Kucheman was responsible for global marketing. He has served on several industry boards, including the board of directors of the Global Health Exchange and on the boards of several non-public companies.

Ronald Malone

Mr. Ronald A. Malone is Independent Director of the company. Mr. Malone has served as a director of Hill-Rom since 2007. He served as Chairman of the Board of Gentiva Health Services from 2002 to 2011, as Chief Executive Officer from 2002 through 2008, and as a director through 2012. He joined Gentiva in 2000 as Executive Vice President and President of Gentiva’s Home Health Division. Prior to joining Gentiva, he served in various positions with Olsten Corporation including Executive Vice President of Olsten Corporation and President, Olsten Staffing Services, United States and Canada. He is a director of Capital Senior Living, Inc., a former director of the National Association for Home Care & Hospice and a former director and chairman of the Alliance for Home Health Quality and Innovation.

Stacy Seng

Ms. Stacy Enxing Seng is Independent Director of the company, Ms. Seng has served as director of Hill-Rom since 2015. She is the former President, Peripheral Vascular of Covidien from 2012 to 2014. Prior to that, she was President, Vascular Therapies, of Covidien from 2010 to 2012. Ms. Enxing Seng joined Covidien in 2010 through the $2.6B acquisition of ev3 Incorporated, where she was a founding member and executive officer responsible for leading their Peripheral Vascular division from 2001 to 2010. Prior to that, she held positions of increasing responsibility with SCIMED, Boston Scientific, American Hospital Supply and Baxter. Ms. Enxing Seng currently is a Venture Partner with Lightstone Venture Capital and serves on the boards of Sonova Holding AG, Solace Therapeutics, and Spirox, Inc., and was formerly on the boards of FIRE 1 Medical Incubator and CV Ingenuity. Ms. Enxing Seng has broad experience as a former senior executive responsible for a world-wide business unit of a major medical device company. In addition, she has significant experience as a co-founder of a successful medical device start-up. Her operational experience at a large medical device company, combined with her broad scope experience gained from her role as a co-founder of a medical device company, provide the Board with valuable insights across marketing, sales, innovation and a variety of other medical device related areas.